Age
|
1.01 |
1.00–1.01 |
<0.001 |
Female vs. Male
|
0.72 |
0.7–0.74 |
<0.001 |
Race
|
|
|
|
African Americans vs. Caucasians |
2.37 |
2.11–2.67 |
<0.001 |
Others vs. Caucasians |
1.06 |
0.95–1.17 |
0.313 |
Invasive melanoma subtype
|
|
|
|
Ocular vs. Cutaneous |
0.37 |
0.33–0.41 |
<0.001 |
Mucosal vs. Cutaneous |
2.46 |
2.28–2.66 |
<0.001 |
Charlson Deyo score
|
|
|
|
1 vs. 0 |
1.43 |
1.37–1.49 |
<0.001 |
2 vs. 0 |
2.05 |
1.91–2.2 |
<0.001 |
3 vs. 0 |
3.48 |
3.16–3.83 |
<0.001 |
Socioeconomic Status: Median household income for patient’s zip code
|
|
|
|
40,227–50,353 (level 2) vs. <40,227 (level 1) |
1.03 |
0.96–1.1 |
0.372 |
50,354–63,332 (level 3) vs. <40,227 (level 1) |
0.99 |
0.93–1.06 |
0.785 |
>46,000 to >63,333 (level 4) vs. <40,227 (level 1) |
0.97 |
0.91–1.05 |
0.476 |
Number of adults in the patient’s zip code who did not graduate from high school
|
|
|
|
20–28.9% vs. >29% |
0.91 |
0.85–0.96 |
<0.001 |
14–18.9% vs. >29% |
0.83 |
0.78–0.89 |
<0.001 |
<14% vs. >29% |
0.75 |
0.71–0.81 |
<0.001 |
Treating Facility Type
|
|
|
|
Academic/research program vs. Community cancer program |
0.76 |
0.74–0.79 |
<0.001 |
Integrated network cancer program vs. Community cancer program |
1.01 |
0.97–1.06 |
0.65 |
Insurance Status
|
|
|
|
Private insurance vs. Not insured |
0.35 |
0.32–0.37 |
<0.001 |
Medicaid vs. Not insured |
1.26 |
1.15–1.39 |
<0.001 |
Medicare or other government insurance vs. Not insured |
0.44 |
0.4–0.47 |
<0.001 |
Geographical location
|
|
|
|
West vs. North East |
1.09 |
1.04–1.15 |
<0.001 |
Midwest vs. North East |
1.01 |
0.97–1.06 |
0.53 |
South vs. North East |
1.06 |
1.01–1.1 |
0.01 |